{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T15:21:24Z","timestamp":1772119284719,"version":"3.50.1"},"reference-count":14,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2024,5,11]],"date-time":"2024-05-11T00:00:00Z","timestamp":1715385600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,5,11]],"date-time":"2024-05-11T00:00:00Z","timestamp":1715385600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Dermatol Res"],"DOI":"10.1007\/s00403-024-02890-9","type":"journal-article","created":{"date-parts":[[2024,5,11]],"date-time":"2024-05-11T12:01:36Z","timestamp":1715428896000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Rx -to- OTC switch increased access and lowered cost of topical adapalene"],"prefix":"10.1007","volume":"316","author":[{"given":"William","family":"Fix","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sapana","family":"Desai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dillon","family":"Nussbaum","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adam","family":"Friedman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,5,11]]},"reference":[{"key":"2890_CR1","doi-asserted-by":"publisher","unstructured":"Weiss J, Mallavalli S, Meckfessel M, Griffin S, Wagner N Safe use of Adapalene 0.1% gel in a non-prescription environment. J Drugs Dermatology: JDD. 12\/01\/2021 2021;20(12)https:\/\/doi.org\/10.36849\/jdd.6527","DOI":"10.36849\/jdd.6527"},{"key":"2890_CR2","doi-asserted-by":"publisher","unstructured":"Shah N, Ghatnekar S, Nambudiri V Variability of over-the-counter spending on acne treatment across race and demographic characteristics. Clin Dermatol 04\/13\/2022 2022;https:\/\/doi.org\/10.1016\/j.clindermatol.2022.02.017","DOI":"10.1016\/j.clindermatol.2022.02.017"},{"key":"2890_CR3","unstructured":"Medicare Provider Utilization and Payment Data Part D Prescriber | CMS. www.cms.gov. https:\/\/www.cms.gov\/Research-Statistics-Data-and-Systems\/Statistics-Trends-and Reports\/Medicare-Provider-Charge-Data\/Part-D-Prescriber"},{"issue":"3","key":"2890_CR4","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/0168-8510(90)90424-C","volume":"16","author":"M Ryan","year":"1990","unstructured":"Ryan M, Yule B (1990) Switching drugs from prescription-only to over-the-counter availability: economic benefits in the United Kingdom. Health Policy Dec 16(3):233\u2013239","journal-title":"Health Policy Dec"},{"issue":"6","key":"2890_CR5","first-page":"374","volume":"11","author":"P Sullivan","year":"2005","unstructured":"Sullivan P, Nair K, Patel B (2005) The effect of the Rx-to-OTC switch of loratadine and changes in prescription drug benefits on utilization and cost of therapy. Am J Managed Care June 11(6):374\u2013382","journal-title":"Am J Managed Care June"},{"issue":"12","key":"2890_CR6","doi-asserted-by":"publisher","first-page":"1382","DOI":"10.1097\/01.MLR.0000100584.18276.C4","volume":"41","author":"P Sullivan","year":"2003","unstructured":"Sullivan P, Follin S, Nichol M (2003) Transitioning the second-generation antihistamines to over-the-counter status: a cost-effectiveness analysis. Med Care Dec 41(12):1382\u20131395","journal-title":"Med Care Dec"},{"issue":"6","key":"2890_CR7","doi-asserted-by":"publisher","first-page":"835","DOI":"10.3111\/13696998.2013.793693","volume":"16","author":"J Cohen","year":"2013","unstructured":"Cohen J, Miller A, Toumi M (2013) Assessing the economic impact of Rx-to-OTC switches: systematic review and guidelines for future development. J Med Econ 16(6):835\u2013844","journal-title":"J Med Econ"},{"issue":"11","key":"2890_CR8","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1056\/NEJMra011080","volume":"345","author":"E Brass","year":"2001","unstructured":"Brass E (2001) Changing the status of drugs from prescription to over-the-counter availability. New Engl J Med September 345(11):810\u2013816","journal-title":"New Engl J Med September"},{"issue":"1","key":"2890_CR9","first-page":"42","volume":"20","author":"M Pawaskar","year":"2007","unstructured":"Pawaskar M, Balkrishnan R (2007) Switching from prescription to over-the counter medications: a consumer and managed care perspective. Managed Care Interface January 20(1):42\u201347","journal-title":"Managed Care Interface January"},{"key":"2890_CR10","unstructured":"Information Resources, Inc http:\/\/www.iriworldwide.com\/en-us\/solutions\/academic-data-set"},{"key":"2890_CR11","unstructured":"ClinCalc DrugStats Database https:\/\/clincalc.com\/DrugStats\/Drugs\/Adapalene"},{"key":"2890_CR12","unstructured":"Medical Expenditure Panel Survey https:\/\/meps.ahrq.gov\/mepsweb\/"},{"key":"2890_CR13","unstructured":"Medicare Provider Utilization and Payment Data Part D Prescriber | CMS. www.cms.gov. https:\/\/www.cms.gov\/Research-Statistics-Data-and-Systems\/Statistics-Trends-and"},{"key":"2890_CR14","unstructured":"Google Trends https:\/\/trends.google.com\/trends\/"}],"container-title":["Archives of Dermatological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00403-024-02890-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00403-024-02890-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00403-024-02890-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,4]],"date-time":"2024-06-04T05:49:14Z","timestamp":1717480154000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00403-024-02890-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,11]]},"references-count":14,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2024,7]]}},"alternative-id":["2890"],"URL":"https:\/\/doi.org\/10.1007\/s00403-024-02890-9","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-3878852\/v1","asserted-by":"object"}]},"ISSN":["1432-069X"],"issn-type":[{"value":"1432-069X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,5,11]]},"assertion":[{"value":"19 January 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 January 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 April 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 May 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All authors certify that they have no affiliations with or involvement in any organization or entity with any financial interest or non-financial interest in the subject matter or materials discussed in this manuscript. The data that support the findings of this study are openly available in Information Resources, Inc. at\n                      \n                      [\n                      \n                      ], ClinCalc DrugStats Database at\n                      \n                      [\n                      \n                      ], Medical Expenditure Panel Survey at\n                      \n                      [\n                      \n                      ], Medicare Part D Provider Utilization and Payment Data database at data.cms.gov [\n                      \n                      ], and Google Trends at\n                      \n                      [\n                      \n                      ].","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Statements and Declarations"}},{"value":"Not Applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Patient consent"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"155"}}